Dosing Recommendation for Ampicillin-Sulbactam in a 21 kg Child
For a 21 kg child, administer ampicillin-sulbactam 525-1050 mg (ampicillin component) IV every 6 hours, which corresponds to 100-200 mg/kg/day of ampicillin divided every 6 hours. This translates to a total daily dose of 2100-4200 mg of ampicillin (1050-2100 mg of sulbactam), given as 4 divided doses.
Practical Dosing Calculation
Based on the guideline recommendations 1:
- Standard dosing range: 100-200 mg ampicillin/kg/day divided every 6 hours
- For 21 kg patient:
- Lower end: 100 mg/kg/day = 2100 mg/day ÷ 4 doses = 525 mg ampicillin per dose (with 262.5 mg sulbactam)
- Upper end: 200 mg/kg/day = 4200 mg/day ÷ 4 doses = 1050 mg ampicillin per dose (with 525 mg sulbactam)
Dosing Algorithm by Clinical Scenario
Choose the appropriate dose based on infection severity and site:
- Mild-to-moderate infections (skin/soft tissue, community-acquired pneumonia): Use 100-150 mg/kg/day (525-787.5 mg ampicillin per dose)
- Severe infections (intra-abdominal, complicated pneumonia, sepsis): Use 150-200 mg/kg/day (787.5-1050 mg ampicillin per dose)
The FDA label confirms pediatric dosing at 300 mg/kg/day total (ampicillin + sulbactam combined), which equals 200 mg ampicillin/100 mg sulbactam per kg per day 2. This aligns with the upper end of guideline recommendations.
Administration Details
- Route: Intravenous infusion over 15-30 minutes 2
- Frequency: Every 6 hours (4 times daily)
- Maximum sulbactam: Do not exceed 4 grams sulbactam per day (not applicable to this 21 kg patient at recommended doses)
- Duration: Typically not exceeding 14 days of IV therapy 2
Important Caveats
Renal function adjustment: If the child has impaired renal function, dosing frequency must be reduced. For creatinine clearance 15-29 mL/min/1.73m², give every 12 hours; for CrCl 5-14 mL/min/1.73m², give every 24 hours 2.
Weight consideration: Since this patient weighs 21 kg (well under the 40 kg threshold), use pediatric dosing. Patients ≥40 kg should receive adult dosing 2.
Clinical efficacy data: Studies demonstrate 90-95% clinical efficacy with dosing regimens of 150-300 mg/kg/day in pediatric skin/soft tissue and respiratory infections 3, 4. The pharmacokinetic profile in children is comparable to adults, with mean half-lives of approximately 0.77-0.81 hours 5.